PowderJect - About the company
PowderJect is an acquired company based in Oxford (United Kingdom), founded in 2013. It operates as a Developer of vaccines and drug delivery tools. The company has 14 active competitors, including 3 funded and 3 that have exited. Its top competitors include companies like Elektrofi, Nutriband and Pharma Latch.
Company Details
Developer of vaccines and drug delivery tools. The company provides needle-free drug delivery technologies to deliver vaccines via a powder absorbed in the patient's epidermis, rather than by traditional injection methods.
- Website
- powderject.com
Key Metrics
Founded Year
2013
Location
Oxford, United Kingdom
Stage
Acquired
Ranked
10th among 14 active competitors
Exit Details
Acquired
PowderJect's acquisition details
PowderJect got acquired on Jun 01, 2003.
Click here to take a look at PowderJect's acquisition in detail
Sign up to download PowderJect's company profile
PowderJect's funding and investors
PowderJect has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
PowderJect's Competitors and alternates
Top competitors of PowderJect include Elektrofi, Nutriband and Pharma Latch. Here is the list of Top 10 competitors of PowderJect, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Elektrofi 2016, Boston (United States), Acquired | Digital platform transforming the delivery of biologic medicines | $152M | 64/100 | |
2nd | Nutriband 2012, Orlando (United States), Public | Transdermal drug delivery technologies improving patient safety and deterring drug abuse | $215K | - | 52/100 |
3rd |  Pharma Latch 2019, Dublin (Ireland), Seed | Provider of intradermal injection devices based on platform technology for drug and vaccine delivery | - | 32/100 | |
4th | Developer of technology for controlling ion activity in biological systems | $402K | 30/100 | ||
5th | Developer of drug delivery device | - | 26/100 | ||
6th |  Hypospray Pharma 2019, Palm Beach Gardens (United States), Unfunded | Developer of transdermal drug delivery for the management of various diseases | - | - | 24/100 |
7th |  Orlance 2016, Seattle (United States), Funding Raised | Developer of a platform to deliver nucleic acid vaccines and related therapies | - | 24/100 | |
8th |  Wuhan Tianshiwei Holding 2018, Wuhan (China), Series A | Developer of a technology for transdermal drug delivery device | - | 22/100 | |
9th |  Dyna Biosystems 2020, Vancouver (Canada), Unfunded | Developer of non-invasive transdermal drug delivery devices | - | - | 22/100 |
10th |  PowderJect 2013, Oxford (United Kingdom), Acquired | Developer of vaccines and drug delivery tools | - | - | 20/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on PowderJect's competitors? Click here to see the top ones
PowderJect's Investments and acquisitions
PowderJect has made no investments or acquisitions yet.
Reports related to PowderJect
Here is the latest report on PowderJect's geography:
News related to PowderJect
•
Centauri acquires Alphamer technology from AltermuneDrug Target Review•Jan 18, 2016•Centauri Therapeutics, Altermune, PowderMed, Pfizer and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about PowderJect
Explore our recently published companies
